ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Corporate Finance Associates Worldwide Appoints Albert T. Kelley as Advisor to Its Healthcare Practice, Focused on Medical Technology

By: PR Leap
(PRLeap.com) Veteran med‑tech CEO and board leader brings decades of operating and transaction experience across devices, diagnostics, and health IT.

LOS ANGELES, CA - November 3, 2025 Corporate Finance Associates Worldwide (CFAW), an independent international investment banking firm serving middle‑market businesses since 1956, today announced that Albert T. Kelley has joined the firm as an Advisor in its Healthcare Practice with a focus on medical technology-including medical devices, surgical equipment & supplies, medical testing equipment, and healthcare IT.

"Albert pairs deep operating experience with a clear understanding of what drives value in med‑tech transactions," said Patrick Powell, Managing Director and member of the Healthcare Practice at CFAW. "His track record leading and scaling innovative companies will help our clients navigate strategic alternatives and achieve superior outcomes."

"CFAW's global platform, middle‑market focus, and senior‑level attention create an ideal environment to advise med‑tech founders, CEOs, and investors," said Albert T. Kelley. "I'm excited to support clients across devices, diagnostics, and health IT-bringing operating expertise to every stage of the deal process."

Kelley has invested in, led, staffed, and built global medical technology, diagnostics, and software companies at crucial stages of development-from start‑up to acquisition or IPO. Over his career, he has launched 31 products and built direct operations and joint ventures across North America, Europe, the Middle East, South America, and the Asia‑Pacific region. His prior leadership roles include President/CEO and Board Member of Perthera AI, and CEO of OpenMed and Applied Fiberoptics; earlier in his career, he held senior roles at ZOLL Medical and Catheter Technology (Groshong®). Among the outcomes associated with his tenure: ZOLL Medical's growth from approximately US$4 million to US$48 million in annual revenue, followed by its acquisition for approximately US$2.2 billion, and Catheter Technology's US$60 million sale.

About Corporate Finance Associates Worldwide (CFAW)
Founded in 1956, CFAW is an independent international investment banking firm that provides financial advisory services and access to capital resources to help business owners successfully sell, buy, or finance a business. Headquartered in Los Angeles, CFAW serves middle‑market clients through 30+ offices across North America and international locations. For more information, visit www.cfaw.com.

GET IN TOUCH
Kim Levin
Corporate Finance Associates

http://www.cfaw.com

You can see the original version and more on PRLeap here: http://www.prleap.com/pr/307967/corporate-finance-associates-worldwide-appoints-albert-t-kelley-as-advisor-to-its-healthcare-practice-focused-on-medical

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.20
+0.88 (0.35%)
AAPL  270.14
+0.10 (0.04%)
AMD  256.33
+6.28 (2.51%)
BAC  52.45
-1.09 (-2.04%)
GOOG  284.75
+6.69 (2.41%)
META  635.95
+8.63 (1.38%)
MSFT  507.16
-7.17 (-1.39%)
NVDA  195.21
-3.48 (-1.75%)
ORCL  250.31
+2.14 (0.86%)
TSLA  462.07
+17.81 (4.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.